Pricing Log in Create free account
Friday 6 November 2026 Export BRKR’s income statement to Excel — free account

Bruker Corporation

BRKR Healthcare Medical Devices

Bruker Corporation’s revenue for fiscal 2025 (year ended December 2025) was $3.4 billion, up 2.08% from fiscal 2024.

Revenue
+1.57%
EPS
−75.4%
Free cash flow
+278.7%
Total debt
−14.7%

Quarter to September 2026, against a year earlier

61.17 3.11 +5.36%
Market cap
$8.9B
P/E
0.0×
Fwd P/E
−412×
Dividend yield
0.34%
F-score
4/9
Altman Z
2.43
Beneish M
−2.56
Dividend safety
34/100
Overview Business Profile Earnings & Analysis
Financials
Income Statement Balance Sheet Cash Flow Metrics & Ratios
Segments Valuation Filings

Bruker Corporation (BRKR) EV/EBITDA

Alert me on EV/EBITDA

As of 5 November 2026, Bruker Corporation (BRKR) trades at a EV/EBITDA of 66.0×. Over the past ten years it has ranged from 13.0× (December 2018) to 72.3× (September 2026); the current reading is higher than 100% of that period. That is above the Medical Devices industry median of 11.5× and above the Healthcare sector median of 8.4×.

EV/EBITDA, daily

Embed this chart

Annual newest first

Period EV/EBITDA Change
FY2025 30.2× 24.07%
FY2024 24.4× 18.17%
FY2023 20.6× (0.78%)
FY2022 20.8× (18.88%)
FY2021 25.6× 0.05%
FY2020 25.6× 19.92%
FY2019 21.4× 49.68%
FY2018 14.3× (25.61%)
FY2017 19.2× 33.37%
FY2016 14.4× (26.26%)

Quarterly newest first

Period EV/EBITDA Change
Sep 2026 72.3× 33.42%
Jun 2026 54.2× 111.56%
Mar 2026 25.6× (15.31%)
Dec 2025 30.2× 26.93%
43 more quarters

Against its own ten years

Low 13.0× High 72.3×
Ten-year median 20.1×
Current reading's percentile 100

EV/EBITDA against peers

Company EV/EBITDA
BIO Bio-Rad Laboratories, Inc. compare n/m
GKOS Glaukos Corporation compare n/m
TXG 10x Genomics compare n/m
BIO.B Bio-Rad Laboratories, Inc. compare n/m
SNN Smith & Nephew SNATS, Inc. compare 6.5×
GMED Globus Medical, Inc. compare 11.9×
PODD Insulet Corporation compare 16.1×
PEN Penumbra, Inc. compare 57.3×
BRKR Bruker Corporation 66.0×
Medical Devices industry median 11.5×
Healthcare sector median 8.4×
Market median 10.9×

What EV/EBITDA is

Enterprise Value over EBITDA tells an investor how the market values a whole company, with debt added and cash taken off, against its operating earnings.

((Stock Price × Shares (Basic, Weighted) (latest quarter)) + (Long Term Debt (Total) (latest quarter) + Current Part of Debt (latest quarter)) − Cash & Short Term Investments (latest quarter)) ÷ EBITDA (TTM)

The full definition of EV/EBITDA →

More on BRKR